Company: HROW
Filing Date: 2025-11-10
Form Type: 10-Q
Source: 0001493152-25-021562
Chunk: 38

Company: HARROW, INC.
Filing Date: 2025-11-10
Form: 10-Q
Item: Item 1
Chunk 38
---
 are administered by the Compensation Committee of the Company’s Board of Directors.

    21

Stock
Options

A
summary of stock option activity under the Plans for the nine months ended September 30, 2025 is as follows:

SCHEDULE
OF STOCK OPTION PLAN ACTIVITY

    Number of
 Shares  
    Weighted
 Average
 Exercise Price  
    Weighted
 Average
 Remaining
 Contractual
 Life  
    Aggregate
 Intrinsic Value 
  
    Options outstanding – January 1, 2025 
     2,469,099  
    $6.49  

    Options granted 
     198,500  
    $36.96  

    Options exercised 
     (628,334) 
    $7.99  

    Options cancelled/forfeited 
     (69,944) 
    $15.94  

    Options outstanding – September 30, 2025 
     1,969,321  
    $8.75  
     3.65  
    $77,657,000 
  
    Options exercisable 
     1,660,186  
    $4.84  
     2.62  
    $71,949,000 
  
    Options vested and expected to vest 
     1,921,309  
    $8.14  
     3.50  
    $76,921,000 

The
aggregate intrinsic value in the table above represents the total pre-tax amount of the proceeds, net of exercise price, which would
have been received by option holders if all option holders had exercised and immediately sold all shares underlying options with an exercise
price lower than the market price on September 30, 2025, based on the closing price of the Company’s common stock of $48.18 on
that date.

During
the nine months ended September 30, 2025, the Company granted stock options to certain employees. The stock options were granted with
an exercise price equal to the current market price of the Company’s common stock, as reported by the securities exchange on which
the common stock was then listed, at the grant date and have contractual terms of ten years. Vesting terms for options granted to employees
during the three and nine months ended September 30, 2025 included the following vesting schedule: 25% of the shares subject to the option
vest and become exercisable